Financials

  • Market Capitalization 9.97 M
  • Employee 8
  • Founded 2014
  • CEO N/A
  • Website www.metaviatx.com
  • Headquarter Delaware, United States
  • FIGI BBG009YPPXR8
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-0.29
Rapporto prezzo/fatturato
5.03

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
4801
TRAW
Traws Pharma, Inc. - Common Stock
0.70 USD+2.94%+1.45%-7.89%-53.33%10.61 M USD
4808
VTGN
Vistagen Therapeutics, Inc. - Common Stock
0.25 USD0.00%+8.70%-56.90%-51.47%10.26 M USD
4815
CVM
Cel-Sci Corporation Common Stock
1.14 USD-7.32%-10.24%+11.76%-77.86%9.68 M USD
4826
AEON
AEON Biopharma, Inc. Class A Common Stock
0.35 USD+9.38%-50.00%-47.76%-66.35%9.21 M USD